tiprankstipranks
Ramsay Health Care (RMSYF)
OTHER OTC:RMSYF
US Market

Ramsay Health Care (RMSYF) Earnings Dates, Call Summary & Reports

14 Followers

Earnings Data

Report Date
Aug 27, 2026
TBA (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
0.48
Last Year’s EPS
0.39
Same Quarter Last Year
Based on 8 Analysts Ratings

Earnings Call Summary

Q2 2026
Earnings Call Date:Feb 25, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
Positive overall: the call emphasizes strong, broad-based underlying profit growth driven by Australia, improved cash flow, active capital-discipline measures, and material operational progress on the transformation agenda. These positives are tempered by clear and material regional challenges — notably UK NHS funding uncertainty, Elysium underperformance, French funding headwinds and elevated leverage in Ramsay Sante — which management is actively addressing through turnaround programs, refinancing and a proposed demerger. The balance of the narrative is constructive but cautious, with meaningful risks to monitor.
Company Guidance
Management's guidance for FY26 reiterated continued Australia EBIT growth momentum and several quantified items: net financing costs forecast $590–610m, underlying effective tax rate ~35%, group CapEx reduced to $755–795m with Australian development CapEx now expected $170–190m and 23 new theatres/procedure rooms scheduled to open in FY26, and a full‑year dividend payout ratio of 60–70% of underlying NPAT (interim fully franked dividend $0.425/share, +6.3%, 60% payout for the half). They expect Australia to sustain momentum after H1 results (H1 underlying EBIT +7.3%, underlying NPAT +8.1%; Australia underlying EBIT +7.1%, revenue +8.2%, private portfolio revenue +8.7%, hospital admissions +3.1%, core surgical admissions +5.7%, theatre utilisation +1.3% y/y and a 40bp margin lift excluding Joondalup), while U.K. NHS activity is expected to remain negative in Q3 with potential additional funding from 1 April; Elysium’s turnaround is expected to gain traction after 163 beds closed in H1. They also confirmed corporate actions and balance‑sheet metrics: the proposed Ramsay Sante in‑specie distribution targeted for completion in Dec‑2026 (Sante H1 underlying EBIT +4.4% cc, leverage 5.3x, EUR391m liquidity), the National Capital Private Hospital acquisition to transition in Q1 FY27 and be EPS‑accretive in year one, consolidated net debt $5.1bn, Funding Group leverage excl. Sante 2.22x (<2.5x target), and operating cash flow improvement to $350m (up 16.9%).
Group profit growth and shareholder return
Reported 7.3% growth in underlying EBIT and 8.1% growth in underlying NPAT for the half. Board declared a fully franked dividend of $0.425 per share, up 6.3%, representing a 60% payout ratio of underlying earnings.
Strong Australian performance driving results
Australia delivered underlying EBIT growth of 7.1%, customer revenue up 8.2% and private hospital revenue up 8.7%. Core surgical admissions increased 5.7% (day admissions outpacing overnight), inpatient activity and case acuity rose, and EBIT margins (ex-Joondalup) improved by ~40 basis points. Theatre utilization improved (c.1.3% 12-month rolling improvement).
Operational progress and transformation momentum
Group executive refresh complete and multiyear transformation underway. Patient, doctor and people NPS improved; 23% growth in clinical trials activity; 23 new theatres/procedure rooms scheduled in FY26; targeted 'Big 5' hospital initiatives and pilot programs delivering cost efficiencies. Digital and data OpEx on track to be at or below FY25 spend.
Cashflow, refinancing and leverage management
Operating cash flow improved 16.9% to $350m. Funding Group leverage excluding Ramsay Sante is 2.22x (within target <2.5x). Successfully refinanced syndicated debt, extending tenure and reducing margin by 30bp; weighted average cost of debt down c.20bp since 30 Jun 2025. Majority of debt hedged (c.65% hedged) at below current spot base rates.
Ramsay Sante and Nordics momentum
Ramsay Sante delivered a 4.4% increase in underlying EBIT in constant currency, driven by strong Swedish performance. New multi-year contract at St. Goran commenced 5 Jan 2026 on improved terms to support Nordic results.
Proactive capital allocation and de-risking moves
Management progressing proposed in‑specie distribution (demerger) of Ramsay Sante to simplify group focus. Development CapEx guidance trimmed (Australia development CapEx now $170m–$190m; Group CapEx reduced to $755m–$795m, $40m below prior range) reflecting disciplined capital allocation and utilization-first approach. Proposed acquisition of National Capital Private Hospital expected to be EPS accretive in first 12 months.

Ramsay Health Care (RMSYF) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

RMSYF Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 27, 2026
2026 (Q4)
0.48 / -
0.392
Feb 25, 2026
2026 (Q2)
0.42 / 0.50
0.4578.56% (+0.04)
Aug 27, 2025
2025 (Q4)
0.46 / 0.39
0.404-3.11% (-0.01)
Feb 26, 2025
2025 (Q2)
0.44 / 0.46
0.40412.95% (+0.05)
Aug 29, 2024
2024 (Q4)
0.44 / 0.40
0.29934.97% (+0.10)
Feb 28, 2024
2024 (Q2)
0.36 / 0.40
0.579-30.16% (-0.17)
Aug 23, 2023
2023 (Q4)
0.49 / 0.30
0.34-11.91% (-0.04)
Feb 23, 2023
2023 (Q2)
0.56 / 0.58
0.47322.45% (+0.11)
Aug 25, 2022
2022 (Q4)
0.46 / 0.34
0.67-49.27% (-0.33)
Feb 23, 2022
2022 (Q2)
0.64 / 0.47
0.676-30.13% (-0.20)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

RMSYF Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 25, 2026
$26.48$29.08+9.83%
Aug 27, 2025
$23.50$23.500.00%
Feb 26, 2025
$20.68$22.02+6.50%
Aug 29, 2024
$29.05$26.86-7.57%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ramsay Health Care (RMSYF) report earnings?
Ramsay Health Care (RMSYF) is schdueled to report earning on Aug 27, 2026, TBA (Confirmed).
    What is Ramsay Health Care (RMSYF) earnings time?
    Ramsay Health Care (RMSYF) earnings time is at Aug 27, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is RMSYF EPS forecast?
          RMSYF EPS forecast for the fiscal quarter 2026 (Q4) is 0.48.